{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:07:41Z","timestamp":1793822861701,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-025-01305-7","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:21:40Z","timestamp":1749601300000},"page":"918-934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation"],"prefix":"10.1038","volume":"22","author":[{"given":"Keke","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiteng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-2843","authenticated-orcid":false,"given":"Tianlei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-633X","authenticated-orcid":false,"given":"Jiaxu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"1305_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41385-022-00551-6","volume":"15","author":"CS de Paiva","year":"2022","unstructured":"de Paiva CS, St Leger AJ, Caspi RR. Mucosal immunology of the ocular surface. Mucosal Immunol. 2022;15:1143\u201357.","journal-title":"Mucosal Immunol"},{"key":"1305_CR2","first-page":"506","volume":"36","author":"RG Jones","year":"2016","unstructured":"Jones RG, Martino A. Targeted localized use of therapeutic antibodies: a review of nonsystemic, topical and oral applications. Crit Rev Biotechnol. 2016;36:506\u201320.","journal-title":"Crit Rev Biotechnol"},{"key":"1305_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMra2032506","volume":"386","author":"GG Brusselle","year":"2022","unstructured":"Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386:157\u201371.","journal-title":"N Engl J Med"},{"key":"1305_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","volume":"7","author":"Y Weng","year":"2017","unstructured":"Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 2017;7:281\u201391.","journal-title":"Acta Pharm Sin B"},{"key":"1305_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1067\/mai.2001.116576","volume":"108","author":"TK Hart","year":"2001","unstructured":"Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol. 2001;108:250\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"1305_CR6","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1007\/s00253-021-11488-4","volume":"105","author":"HA Parray","year":"2021","unstructured":"Parray HA, Shukla S, Perween R, Khatri R, Shrivastava T, Singh V, et al. Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections. Appl Microbiol Biotechnol. 2021;105:6315\u201332.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Martin","year":"2011","unstructured":"Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897\u2013908.","journal-title":"N Engl J Med"},{"key":"1305_CR8","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1167\/iovs.16-20072","volume":"58","author":"F de Cogan","year":"2017","unstructured":"de Cogan F, Hill LJ, Lynch A, Morgan-Warren PJ, Lechner J, Berwick MR, et al. Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides. Invest Ophthalmol Vis Sci. 2017;58:2578\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1305_CR9","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.2147\/OPTH.S366836","volume":"16","author":"L Shettle","year":"2022","unstructured":"Shettle L, McLaurin E, Martel J, Seaman JW 3rd, Weissgerber G. Topical anti-TNF\u03b1 agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease: a randomized phase II study. Clin Ophthalmol. 2022;16:2167\u201377.","journal-title":"Clin Ophthalmol"},{"key":"1305_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/d41573-019-00104-w","volume":"18","author":"C Morrison","year":"2019","unstructured":"Morrison C. Nanobody approval gives domain antibodies a boost. Nat Rev Drug Discov. 2019;18:485\u20137.","journal-title":"Nat Rev Drug Discov"},{"key":"1305_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82:775\u201397.","journal-title":"Annu Rev Biochem"},{"key":"1305_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chom.2020.04.023","volume":"27","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, et al. Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe. 2020;27:891\u20138.e5.","journal-title":"Cell Host Microbe"},{"key":"1305_CR13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.cell.2022.03.009","volume":"185","author":"C Li","year":"2022","unstructured":"Li C, Zhan W, Yang Z, Tu C, Hu G, Zhang X, et al. Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody. Cell. 2022;185:1389\u2013401.e18.","journal-title":"Cell"},{"key":"1305_CR14","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.ymthe.2022.04.013","volume":"30","author":"Y Wu","year":"2022","unstructured":"Wu Y, Li Q, Kong Y, Wang Z, Lei C, Li J, et al. A highly stable human single-domain antibody\u2012drug conjugate exhibits superior penetration and treatment of solid tumors. Mol Ther. 2022;30:2785\u201399.","journal-title":"Mol Ther"},{"key":"1305_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41573-023-00750-1","volume":"22","author":"P Kolkhir","year":"2023","unstructured":"Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, et al. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat Rev Drug Discov. 2023;22:743\u201367.","journal-title":"Nat Rev Drug Discov"},{"key":"1305_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479\u201390.","journal-title":"Immunity"},{"key":"1305_CR17","doi-asserted-by":"publisher","first-page":"5230716","DOI":"10.1155\/2020\/5230716","volume":"2020","author":"Y Qian","year":"2020","unstructured":"Qian Y, Zhang M. The functional roles of IL-33\/ST2 axis in ocular diseases. Mediators Inflamm. 2020;2020:5230716.","journal-title":"Mediators Inflamm"},{"key":"1305_CR18","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","volume":"3","author":"C Moussion","year":"2008","unstructured":"Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019?. PLoS One. 2008;3:e3331.","journal-title":"PLoS One"},{"key":"1305_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116279119","volume":"119","author":"XM Yi","year":"2022","unstructured":"Yi XM, Li M, Chen YD, Shu HB, Li S. Reciprocal regulation of IL-33 receptor-mediated inflammatory response and pulmonary fibrosis by TRAF6 and USP38. Proc Natl Acad Sci USA. 2022;119:e2116279119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1305_CR20","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","volume":"183","author":"D Pr\u00e9fontaine","year":"2009","unstructured":"Pr\u00e9fontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol. 2009;183:5094\u2013103.","journal-title":"J Immunol"},{"key":"1305_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107847","volume":"225","author":"AK Saikumar Jayalatha","year":"2021","unstructured":"Saikumar Jayalatha AK, Hesse L, Ketelaar ME, Koppelman GH, Nawijn MC. The central role of IL-33\/IL-1RL1 pathway in asthma: from pathogenesis to intervention. Pharmacol Ther. 2021;225:107847.","journal-title":"Pharmacol Ther"},{"key":"1305_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/985301","volume":"2013","author":"S Tang","year":"2013","unstructured":"Tang S, Huang H, Hu F, Zhou W, Guo J, Jiang H, et al. Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis. Clin Dev Immunol. 2013;2013:985301.","journal-title":"Clin Dev Immunol"},{"key":"1305_CR23","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1172\/JCI65570","volume":"123","author":"DE Byers","year":"2013","unstructured":"Byers DE, Alexander-Brett J, Patel AC, Agapov E, Dang-Vu G, Jin X, et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest. 2013;123:3967\u201382.","journal-title":"J Clin Invest"},{"key":"1305_CR24","first-page":"583","volume":"25","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang H. Upregulation of the IL-33\/ST2 pathway in dry eye. Mol Vis. 2019;25:583\u201392.","journal-title":"Mol Vis"},{"key":"1305_CR25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jaci.2019.08.039","volume":"144","author":"J Allinne","year":"2019","unstructured":"Allinne J, Scott G, Lim WK, Birchard D, Erjef\u00e4lt JS, Sand\u00e9n C, et al. IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation. J Allergy Clin Immunol. 2019;144:1624\u201337.e10.","journal-title":"J Allergy Clin Immunol"},{"key":"1305_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36642-y","volume":"13","author":"E England","year":"2023","unstructured":"England E, Rees DG, Scott IC, Carmen S, Chan DTY, Chaillan Huntington CE, et al. Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signaling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction. Sci Rep. 2023;13:9825.","journal-title":"Sci Rep"},{"key":"1305_CR27","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","volume":"385","author":"ME Wechsler","year":"2021","unstructured":"Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma. N Engl J Med. 2021;385:1656\u201368.","journal-title":"N Engl J Med"},{"key":"1305_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA. 2007;104:282\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1305_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","volume":"40","author":"GK Dwyer","year":"2022","unstructured":"Dwyer GK, D\u2019Cruz LM, Turnquist HR. Emerging functions of IL-33 in homeostasis and immunity. Annu Rev Immunol. 2022;40:15\u201343.","journal-title":"Annu Rev Immunol"},{"key":"1305_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676\u201389.","journal-title":"Nat Rev Immunol"},{"key":"1305_CR31","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.1007\/s00432-023-05367-w","volume":"149","author":"K Cao","year":"2023","unstructured":"Cao K, Liu Z, Liu J, Hu Q, Shan W, Hu B, et al. Constitutive photomorphogenic protein 1 ubiquitinates interleukin-1 receptor accessory protein in human liver cancer. J Cancer Res Clin Oncol. 2023;149:16247\u201360.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1305_CR32","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1073\/pnas.1308651110","volume":"110","author":"X Liu","year":"2013","unstructured":"Liu X, Hammel M, He Y, Tainer JA, Jeng US, Zhang L, et al. Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci USA. 2013;110:14918\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1305_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.immuni.2017.08.004","volume":"47","author":"S G\u00fcnther","year":"2017","unstructured":"G\u00fcnther S, Deredge D, Bowers AL, Luchini A, Bonsor DA, Beadenkopf R, et al. IL-1 family cytokines use distinct molecular mechanisms to signal through their shared coreceptor. Immunity. 2017;47:510\u201323.e4.","journal-title":"Immunity"},{"key":"1305_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109007","volume":"218","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang S, Alemi H, Dohlman T, Dana R. Immune regulation of the ocular surface. Exp Eye Res. 2022;218:109007.","journal-title":"Exp Eye Res"},{"key":"1305_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jtos.2020.12.007","volume":"20","author":"B Ma","year":"2021","unstructured":"Ma B, Zhou Y, Liu R, Zhang K, Yang T, Hu C, et al. Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease. Ocul Surf. 2021;20:70\u201385.","journal-title":"Ocul Surf"},{"key":"1305_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","volume":"126","author":"A Mandal","year":"2018","unstructured":"Mandal A, Pal D, Agrahari V, Trinh HM, Joseph M, Mitra AK. Ocular delivery of proteins and peptides: challenges and novel formulation approaches. Adv Drug Deliv Rev. 2018;126:67\u201395.","journal-title":"Adv Drug Deliv Rev"},{"key":"1305_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1167\/iovs.08-2372","volume":"50","author":"M Ottiger","year":"2009","unstructured":"Ottiger M, Thiel MA, Feige U, Lichtlen P, Urech DM. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer. Invest Ophthalmol Vis Sci. 2009;50:779\u201386.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1305_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jtos.2020.05.002","volume":"18","author":"RB Singh","year":"2020","unstructured":"Singh RB, Blanco T, Mittal SK, Taketani Y, Chauhan SK, Chen Y, et al. Pigment Epithelium-derived Factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease. Ocul Surf. 2020;18:460\u20139.","journal-title":"Ocul Surf"},{"key":"1305_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/imm.12716","volume":"150","author":"JG Galletti","year":"2017","unstructured":"Galletti JG, Guzm\u00e1n M, Giordano MN. Mucosal immune tolerance at the ocular surface in health and disease. Immunology. 2017;150:397\u2013407.","journal-title":"Immunology"},{"key":"1305_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","volume":"31","author":"S Barabino","year":"2012","unstructured":"Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31:271\u201385.","journal-title":"Prog Retin Eye Res"},{"key":"1305_CR41","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1167\/iovs.17-22550","volume":"59","author":"S Maruoka","year":"2018","unstructured":"Maruoka S, Inaba M, Ogata N. Activation of dendritic cells in dry eye mouse model. Invest Ophthalmol Vis Sci. 2018;59:3269\u201377.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1305_CR42","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jtos.2018.07.005","volume":"16","author":"X Tan","year":"2018","unstructured":"Tan X, Chen Y, Foulsham W, Amouzegar A, Inomata T, Liu Y, et al. The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf. 2018;16:470\u20137.","journal-title":"Ocul Surf"},{"key":"1305_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438\u2013510.","journal-title":"Ocul Surf"},{"key":"1305_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","volume":"391","author":"A Papi","year":"2018","unstructured":"Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391:783\u2013800.","journal-title":"Lancet"},{"key":"1305_CR45","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","volume":"363","author":"MF Moffatt","year":"2010","unstructured":"Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363:1211\u201321.","journal-title":"N Engl J Med"},{"key":"1305_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"JS Patton","year":"2007","unstructured":"Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6:67\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"1305_CR47","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41590-024-01834-9","volume":"25","author":"G Jin","year":"2024","unstructured":"Jin G, Liu Y, Wang L, He Z, Zhao X, Ma Y, et al. A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice. Nat Immunol. 2024;25:1059\u201372.","journal-title":"Nat Immunol"},{"key":"1305_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrd.2015.12","volume":"15","author":"N Udpa","year":"2016","unstructured":"Udpa N, Million RP. Monoclonal antibody biosimilars. Nat Rev Drug Discov. 2016;15:13\u20134.","journal-title":"Nat Rev Drug Discov"},{"key":"1305_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1574884712666170809124728","volume":"13","author":"S Singh","year":"2018","unstructured":"Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, et al. Monoclonal antibodies: a review. Curr Clin Pharmacol. 2018;13:85\u201399.","journal-title":"Curr Clin Pharmacol"},{"key":"1305_CR50","doi-asserted-by":"crossref","unstructured":"Delgado M, Garcia-Sanz JA. Therapeutic monoclonal antibodies against cancer: present and future. Cells. 2023;12:2837.","DOI":"10.3390\/cells12242837"},{"key":"1305_CR51","doi-asserted-by":"crossref","unstructured":"Lo KM, Leger O, Hock B. Antibody engineering. Microbiol Spectr. 2014;2:Aid-0007-2012.","DOI":"10.1128\/microbiolspec.AID-0007-12"},{"key":"1305_CR52","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1167\/iovs.11-7871","volume":"52","author":"MH Dastjerdi","year":"2011","unstructured":"Dastjerdi MH, Sadrai Z, Saban DR, Zhang Q, Dana R. Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci. 2011;52:8718\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1305_CR53","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jaci.2019.02.028","volume":"144","author":"A Holgado","year":"2019","unstructured":"Holgado A, Braun H, Van Nuffel E, Detry S, Schuijs MJ, Deswarte K, et al. IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation. J Allergy Clin Immunol. 2019;144:204\u201315.","journal-title":"J Allergy Clin Immunol"},{"key":"1305_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/imm.13338","volume":"164","author":"JG Galletti","year":"2021","unstructured":"Galletti JG, de Paiva CS. Age-related changes in ocular mucosal tolerance: Lessons learned from gut and respiratory tract immunity. Immunology. 2021;164:43\u201356.","journal-title":"Immunology"},{"key":"1305_CR55","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jtos.2019.08.007","volume":"17","author":"AJ Bron","year":"2019","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. Corrigendum to \u201cTFOS DEWS II pathophysiology report\u201d [Ocul. Surf. 15 (3) (2017) 438-510]. Ocul Surf. 2019;17:842.","journal-title":"Ocul Surf"},{"key":"1305_CR56","first-page":"23","volume":"6","author":"J Lin","year":"2013","unstructured":"Lin J, Zhao GQ, Wang Q, Xu Q, Che CY, Hu LT, et al. Regulation of interleukin 33\/ST2 signaling of human corneal epithelium in allergic diseases. Int J Ophthalmol. 2013;6:23\u20139.","journal-title":"Int J Ophthalmol"},{"key":"1305_CR57","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1167\/iovs.11-9417","volume":"53","author":"KS Na","year":"2012","unstructured":"Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012;53:5443\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1305_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jtos.2020.07.001","volume":"18","author":"H Chen","year":"2020","unstructured":"Chen H, Gan X, Li Y, Gu J, Liu Y, Deng Y, et al. NLRP12- and NLRC4-mediated corneal epithelial pyroptosis is driven by GSDMD cleavage accompanied by IL-33 processing in dry eye. Ocul Surf. 2020;18:783\u201394.","journal-title":"Ocul Surf"},{"key":"1305_CR59","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41385-020-0288-4","volume":"13","author":"J Hu","year":"2020","unstructured":"Hu J, Gao N, Zhang Y, Chen X, Li J, Bian F, et al. IL-33\/ST2\/IL-9\/IL-9R signaling disrupts ocular surface barrier in allergic inflammation. Mucosal Immunol. 2020;13:919\u201330.","journal-title":"Mucosal Immunol"},{"key":"1305_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12929-022-00821-2","volume":"29","author":"HH Wang","year":"2022","unstructured":"Wang HH, Chen WY, Huang YH, Hsu SM, Tsao YP, Hsu YH, et al. Interleukin-20 is involved in dry eye disease and is a potential therapeutic target. J Biomed Sci. 2022;29:36.","journal-title":"J Biomed Sci"},{"key":"1305_CR61","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","volume":"190","author":"DJ Jackson","year":"2014","unstructured":"Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190:1373\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"1305_CR62","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","volume":"9","author":"KF Rabe","year":"2021","unstructured":"Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, et al. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomized, double-blind, phase 2a trial. Lancet Respir Med. 2021;9:1288\u201398.","journal-title":"Lancet Respir Med"},{"key":"1305_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13238-017-0473-8","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Mathieu M, Brezski RJ. IgG Fc engineering to modulate antibody effector functions. Protein Cell. 2018;9:63\u201373.","journal-title":"Protein Cell"},{"key":"1305_CR64","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.2147\/JIR.S320287","volume":"14","author":"AJ Okragly","year":"2021","unstructured":"Okragly AJ, Corwin KB, Elia M, He D, Schroeder O, Zhang Q, et al. Generation and characterization of torudokimab (LY3375880): a monoclonal antibody that neutralizes interleukin-33. J Inflamm Res. 2021;14:3823\u201335.","journal-title":"J Inflamm Res"},{"key":"1305_CR65","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41587-020-0577-1","volume":"38","author":"N Eroshenko","year":"2020","unstructured":"Eroshenko N, Gill T, Keaveney MK, Church GM, Trevejo JM, Rajaniemi H. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nat Biotechnol. 2020;38:789\u201391.","journal-title":"Nat Biotechnol"},{"key":"1305_CR66","doi-asserted-by":"crossref","unstructured":"Meetze K, Mehta NK, Li B, Michaelson JS, Baeuerle PA. CLN-978, a novel half-life extended CD19\/CD3\/HSA-specific T-cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression. J Immunother Cancer. 2023;11:e007398.","DOI":"10.1136\/jitc-2023-007398"},{"key":"1305_CR67","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.bbapap.2014.04.018","volume":"1844","author":"T Ying","year":"2014","unstructured":"Ying T, Gong R, Ju TW, Prabakaran P, Dimitrov DS. Engineered Fc based antibody domains and fragments as novel scaffolds. Biochim Biophys Acta. 2014;1844:1977\u201382.","journal-title":"Biochim Biophys Acta"},{"key":"1305_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fimmu.2014.00146","volume":"5","author":"T Ying","year":"2014","unstructured":"Ying T, Ju TW, Wang Y, Prabakaran P, Dimitrov DS. Interactions of IgG1 CH2 and CH3 Domains with FcRn. Front Immunol. 2014;5:146.","journal-title":"Front Immunol"},{"key":"1305_CR69","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3389\/fimmu.2017.01545","volume":"8","author":"C Wang","year":"2017","unstructured":"Wang C, Wu Y, Wang L, Hong B, Jin Y, Hu D, et al. Engineered soluble monomeric IgG1 Fc with significantly decreased non-specific binding. Front Immunol. 2017;8:1545.","journal-title":"Front Immunol"},{"key":"1305_CR70","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1167\/iovs.04-1326","volume":"46","author":"S Barabino","year":"2005","unstructured":"Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005;46:2766\u201371.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1305_CR71","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12890-021-01698-x","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Gao S, Zhang J, Li C, Li H, Lin J. Interleukin-22 attenuates allergic airway inflammation in ovalbumin-induced asthma mouse model. BMC Pulm Med. 2021;21:385.","journal-title":"BMC Pulm Med"},{"key":"1305_CR72","doi-asserted-by":"publisher","first-page":"e000078","DOI":"10.1136\/bmjophth-2017-000078","volume":"1","author":"HS Lee","year":"2017","unstructured":"Lee HS, Amouzegar A, Dana R. Kinetics of corneal antigen presenting cells in experimental dry eye disease. BMJ Open Ophthalmol. 2017;1:e000078.","journal-title":"BMJ Open Ophthalmol"},{"key":"1305_CR73","doi-asserted-by":"crossref","unstructured":"Ko BY, Xiao Y, Barbosa FL, de Paiva CS, Pflugfelder SC. Goblet cell loss abrogates ocular surface immune tolerance. JCI Insight. 2018;3:e98222.","DOI":"10.1172\/jci.insight.98222"},{"key":"1305_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12243-0","volume":"10","author":"D Tian","year":"2019","unstructured":"Tian D, Yang L, Wang S, Zhu Y, Shi W, Zhang C, et al. Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma. Nat Commun. 2019;10:4246.","journal-title":"Nat Commun"},{"key":"1305_CR75","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-021-00810-1","volume":"6","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wang Y, Jin Y, Zhu Y, Wu Y, Li C, et al. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants. Sig Transduct Target Ther. 2021;6:378.","journal-title":"Sig Transduct Target Ther"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01305-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T20:06:17Z","timestamp":1757189177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01305-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01305-7","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JH, YLW, and KH are listed as inventors on one patent application related to this work. The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}